Novel biphenylene as cisplatin anticancer drug delivery carrier; insight from theoretical perspective
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Fullerene Chemistry and Applications · Carbon Nanotubes in Composites
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (71)
Show source-provided references
1. WHO,“WHO2022,”2022.https://www.who.int/news-room/factsheets/detail/cancer#:∼:text=Key facts,and rectum and prostate cancers.
2. NIH,“Cancerstatistics,”2020.https://www.cancer.gov/aboutcancer/understanding/statistics.
3. Cisplatin: The first metal based anticancer drug10.1016/j.bioorg.2019.102925 ↗
4. Cancer statistics, 2022
5. Targeting cancer stem cell pathways for cancer therapy10.1038/s41392-020-0110-5 ↗
6. Americans’ Health Priorities: Curing Cancer and Controlling Costs10.1377/hlthaff.20.6.222 ↗
7. S. Dasari P. Bernard Tchounwou, Cisplatin in cancer therapy: Molecular mechanisms of action, Eur. J. Pharmacol., vol. 740, (2014) pp. 364–378, 2014, doi: 10.1016/j.ejphar.2014.07.025.10.1016/j.ejphar.2014.07.025 ↗
8. B. Rosenberg, L. V. Camp, CAMP, T. Krigas, Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode, Nature, vol. 205, no. 4972, (1965) pp. 698–699,,doi: 10.1038/205698a0.10.1038/205698a0 ↗
9. “What is cancer,” National Cancer Institute at the National Institutes of Health. https://www.cancer.gov/about-cancer/understanding/what-is-cancer.
10. Cisplatin10.1042/bse0340191 ↗
11. Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches10.2174/0929867054637626 ↗
12. Basic Science / Targeted Therapies for Cancer 200410.1309/5CWPU41AFR1VYM3F ↗
13. Cancer drug delivery in the nano era: An overview and perspectives (Review)10.3892/or.2017.5718 ↗
14. Therapeutic nanoparticles for drug delivery in cancer10.1158/1078-0432.CCR-07-1441 ↗
15. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting10.1016/S0065-2571(00)00013-3 ↗
16. T.M. Allen, Ligand-targeted therapeutics in anticancer therapy, Nat. Rev. Cancer, vol. 2, no. 10, (2002) pp. 750–763, Oct. 2002, doi: 10.1038/nrc903.10.1038/nrc903 ↗
17. Resistance mechanisms associated with altered intracellular distribution of anticancer agents10.1016/S0163-7258(99)00073-X ↗
18. D. Bangham, M. M. Standish, J. C. Watkins, Diffusion of univalent ions across the lamellae of swollen phospholipids, J. Mol. Biol., vol. 13, no. 1, (1965) pp. 238-IN27, , doi: 10.1016/S0022-2836(65)80093-6.10.1016/S0022-2836(65)80093-6 ↗
19. Z. Wang, R. Langer, O.C. Farokhzad, Nanoparticle Delivery of Cancer Drugs, Annu. Rev. Med. , vol. 63, (2012) pp. 185–198, 2011, doi: 10.1146/annurev-med-040210-162544.10.1146/annurev-med-040210-162544 ↗
20. J. Wang, B. Li, L. Qiu, X. Qiao, and H. Yang, Dendrimer ‑ based drug delivery systems : history , challenges , and latest developments, J. Biol. Eng., vol. 5, (2022) pp. 1–12, 2022, doi: 10.1186/s13036-022-00298-5.10.1186/s13036-022-00298-5 ↗
21. “Carbon nanotubes as a novel drug delivery system for anticancer therapy: A review”, Brazilian
22. Non-covalent and reversible functionalization of carbon nanotubes10.3762/bjnano.5.178 ↗
23. PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer Drugs10.1021/ja803688x ↗
24. Adsorption Mechanism of Palbociclib anticancer drug on two different functionalized nanotubes as a drug delivery vehicle: A First Principle’s Study10.1016/j.apsusc.2021.149129 ↗
25. Drug delivery mechanism of doxorubicin and camptothecin on single-walled carbon nanotubes by DFT study
26. Boron nitride nanotubes for delivery of 5-fluorouracil as anticancer drug: a theoretical study10.1016/j.apsusc.2017.09.121 ↗
27. Assessment of the adsorption mechanism of Flutamide anticancer drug on the functionalized single-walled carbon nanotube surface as a drug delivery vehicle: An alternative theoretical approach based on DFT and MD10.1016/j.apsusc.2017.10.165 ↗
28. BNNTs under the influence of external electric field as potential new drug delivery vehicle of Glu, Lys, Gly and Ser amino acids: A first-principles study10.1016/j.apsusc.2014.09.061 ↗
29. Payload delivery of anticancer drug Tegafur with the assistance of graphene oxide nanosheet during biomembrane penetration: Molecular dynamics simulation survey10.1016/j.apsusc.2020.146186 ↗
30. BC3 graphene-like monolayer as a drug delivery system for nitrosourea anticancer drug: A first-principles perception10.1016/j.apsusc.2020.146577 ↗
31. Favipiravir drug molecule adsorbed graphyne as a promising drug delivery vehicle for anti-viral treatment10.1016/j.apsusc.2023.158473 ↗
32. Targeted Single-Wall Carbon Nanotube-Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing Device10.1021/ja803036e ↗
33. Magnetic lymphatic targeting drug delivery system using carbon nanotubes10.1016/j.mehy.2007.07.045 ↗
34. Hydrophilic multi-walled carbon nanotubes decorated with magnetite nanoparticles as lymphatic targeted drug delivery vehiclesw10.1039/b908012k ↗
35. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity † ‡10.1039/C0JM02494E ↗
36. High-Efficiency Loading and Controlled Release of Doxorubicin Hydrochloride on Graphene Oxide10.1021/jp806751k ↗
37. Ultrasmall Reduced Graphene Oxide with High Near-Infrared Absorbance for Photothermal Therapy10.1021/ja2010175 ↗
38. K. Yang, et al., “Graphene in Mice: Ultrahigh In Vivo Tumor Uptake and Efficient Photothermal Therapy,” vol. 10, (2010) pp. 3318–3323, , doi: 10.1021/nl100996u.10.1021/nl100996u ↗
39. Exceedingly higher co-loading of curcumin and paclitaxel onto polymer-functionalized reduced graphene oxide for highly potent synergistic anticancer treatment OPEN10.1038/srep32808 ↗
40. 2022 Locally spontaneous dynamic oxygen migration on biphenyleneene: a DFT study (arXiv:2204.02579)10.1039/D3CP00925D ↗
41. Biphenylene network: A nonbenzenoid carbon allotrope10.1126/science.abg4509 ↗
42. Ab initio molecular dynamics for liquid metals10.1103/PhysRevB.47.558 ↗
43. Efficient iterative schemes for ab initio total-energy calculations using a plane-wave basis set10.1103/PhysRevB.54.11169 ↗
44. Ab initio molecular-dynamics simulation of the liquid-metal–amorphous-semiconductor transition in germanium10.1103/PhysRevB.49.14251 ↗
45. Efficiency of ab-initio total energy calculations for metals and semiconductors using a plane-wave basis set10.1016/0927-0256(96)00008-0 ↗
46. Density functionals from LDA to GGA10.1016/S0927-0256(97)00206-1 ↗
47. Hamada, A van der Waals density functional study of ice Ih, J. Chem. Phys., vol. 133, (2010), pp. 214503, 2010, doi: 10.1063/1.3507916.10.1063/1.3507916 ↗
48. W. Jiang, M. L. Laury, M. Powell, A.K. Wilson, Comparative study of single and double hybrid density functionals for the prediction of 3d transition metal thermochemistry, J. Chem. Theory Comput., vol. 8, no. 11, (2012) pp. 4102–4111, 2012, doi: 10.1021/ct300455e.10.1021/ct300455e ↗
49. S. Grimme, J. Antony, S. Ehrlich, H. Krieg, A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu, J. Chem. Phys., vol. 132, (2010) no. 154104, 2010, doi: 10.1063/1.3382344.10.1063/1.3382344 ↗
50. Special points for Brillouin-zone integrations10.1103/PhysRevB.13.5188 ↗
51. Special points for Brillouin-zone integrations10.1103/PhysRevB.13.5188 ↗
52. DFT study of the molecular and crystal structure and vibrational analysis of cisplatin10.1016/j.saa.2017.01.008 ↗
53. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database10.1186/s13321-018-0283-x ↗
54. Biovia · 2015 · 4
55. (a) K.N. Munny, T. Ahmed, A.A. Piya, et al. Exploring the adsorption performance of doped graphene quantum dots as anticancer drug carriers for cisplatin by DFT, PCM, and COSMO approaches. Struct. Chem. (2023). .10.1007/s11224-023-02150-y ↗
56. (b) I. Alcón et al., Unveiling the Multiradical Character of the Biphenyleneene Network and Its Anisotropic Charge Transport, J. Am. Chem. Soc, vol. 144, (2022) p. 42, , doi: 10.1021/jacs.2c02178.10.1021/jacs.2c02178 ↗
57. Computational Study of Metal Contacts to Monolayer Transition-Metal Dichalcogenide Semiconductors
58. Novel borospherenes as cisplatin anticancer drug delivery systems
59. Copper decorated graphyne as a promising nanocarrier for cisplatin anti-cancer drug: A DFT study
60. W. Tang, E. Sanville, G. Henkelman, A grid-based Bader analysis algorithm without lattice bias., J. Phys. Condens. Matter, vol. 21, no. 8, (2009) p. 84204, Feb. 2009, doi: 10.1088/0953-8984/21/8/084204.10.1088/0953-8984/21/8/084204 ↗
61. S. Simonetti A. Díaz Compa ̃ny G. Brizuela , A. Juan. Theoretical study of cisplatin adsorption on silica. Appl. Surf. Sci. 258 (2011) 1052–1057.10.1016/j.apsusc.2011.08.124 ↗
62. Cobalt nanoparticles for biomedical applications: facile synthesis, physiochemical characterization, cytotoxicity behavior and biocompatibility10.1016/j.apsusc.2017.03.002 ↗
63. Effect of exogenous pH on cell growth of breast cancer cells10.3390/ijms22189910 ↗
64. Therapeutic potential of graphyne as a new drug-delivery system for daunorubicin to treat cancer: A DFT study10.1016/j.molliq.2021.116327 ↗
65. DFT study of the therapeutic potential of borospherene and metalloborospherenes as a new drug-delivery system for the 5-fluorouracil anticancer drug
66. FeC19 cage vehicle for fluorouracil anticancer drug delivery: DFT approach10.1016/j.molliq.2021.115905 ↗
67. DFT study of therapeutic potential of graphitic carbon nitride (g-C3N4) as a new drug delivery system for carboplatin to treat cancer10.1016/j.molliq.2021.115607 ↗
68. Graphene toxicity and future perspectives in healthcare and biomedicine
69. Graphene Nanomaterials: Synthesis, Biocompatibility, and Cytotoxicity10.3390/ijms19113564 ↗
70. Cytotoxic effects of biphenyl and hydroxybiphenyls on isolated rat hepatocytes10.1016/0006-2952(93)90004-G ↗
71. Ae · Drug Chem. Toxicol. · 2019 · 42 · 43010.1080/01480545.2018.1499771 ↗